Emerson Electric (EMR) Earnings Date & Reports

Emerson reported net sales of $4,562 million for Q2 2026, a 3% increase from $4,432 million in the prior year, driven by favorable foreign currency translation (2.5%) but with underlying sales growth of just 0.5%, partly due to software renewal timing and Middle East disruptions. This missed analyst consensus of approximately $4.59–$4.60 billion.

Adjusted diluted EPS was $1.54, up 4% year-over-year from $1.48 and in line with consensus estimates of $1.54. GAAP diluted EPS improved to $1.10 from $0.86. Pretax earnings margin expanded 320 basis points to 17.4%, while adjusted segment EBITA (earnings before interest, taxes, and amortization) margin was 27.6%, slightly below prior year's 28.0%.

Segment highlights included Software & Systems sales up 4% to $1,503 million (adjusted EBITA margin 29.2%), Intelligent Devices up 2% to $2,512 million (27.9% margin), and Test & Measurement up 16% to $414 million (26.3% margin). Operating cash flow was $779 million, and free cash flow $694 million. Guidance was updated for FY2026 with ~4.5% sales growth (~3% underlying), adjusted EPS $6.45–$6.55 (raised midpoint), and Q3 adjusted EPS $1.65–$1.70.

AI Screener

Tickeron’s AI Screener is an AI-powered stock and ETF discovery tool that helps traders and investors filter the market based on technical patterns, fundamentals, trends, volatility, and AI-driven signals. Users can scan thousands of stocks and ETFs using customizable filters such as industry, market capitalization, technical indicators, price patterns, and performance metrics. The screener helps identify trade ideas, trending stocks, breakout candidates, and market opportunities more efficiently than manual screening. Explore the AI Screener today to enhance your investment strategy.

Market Reaction and Investor Sentiment

Following the Q2 earnings release, EMR shares rose about 2% in aftermarket trading to around $137.55, reflecting optimism over the EPS meet, margin resilience, orders growth, and raised full-year guidance despite the revenue shortfall. Some reports noted a modest dip of 1.45–1.5% in extended trading, within historical post-earnings volatility. Sentiment focused on strong backlog visibility (up 9% YoY) and second-half outlook, offsetting concerns from regional headwinds.

Forward Outlook and Key Factors to Monitor

Emerson affirmed confidence in a stronger second half of fiscal 2026, supported by 5% underlying orders growth in Q2 and a 9% higher backlog. The company expects FY2026 underlying sales growth of ~3%, with adjusted segment EBITA margin around 28% and free cash flow of $3.5–$3.6 billion. Capital returns remain on track at ~$2.2 billion, including $1 billion in share repurchases (already $542 million YTD) and $1.2 billion in dividends.

For Q3, sales growth is projected at ~5.5% (~5% underlying), with adjusted EPS of $1.65–$1.70. Key drivers include momentum in growth verticals like power, life sciences, and data centers, bolstered by AI-related demand in test & measurement and software.

Investors should monitor geopolitical risks in the Middle East, software renewal timing, foreign currency impacts (expected 1.5% sales tailwind), and execution on project funnel conversions (~$450 million won in Q2, 85% from growth areas). Margin trends in Intelligent Devices and overall cost discipline will be critical amid volume pressures.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer. Disclaimers and Limitations